TLSI | Richard MarshakChief Commercial Officer | Open market sell$1.45K | -0.4% | $2.67 | $1.45K | May 15, 2026 | May 19, 2026 |
TLSI | Mats WahlstromDirector | Open market purchase$152K | +2.1% | $2.53 | $152K | May 15, 2026 | May 18, 2026 |
TLSI | Michael P. StanskyDirector | Open market purchase$500K | +13.9% | $2.50 | $500K | May 15, 2026 | May 18, 2026 |
TLSI | Michael P. StanskyDirector | Open market purchase$1.03M | +33.3% | $2.50 | $1.03M | May 15, 2026 | May 18, 2026 |
TLSI | Mary T. SzelaCEO and President | Open market purchase$103K | +3.9% | $2.59 | $103K | May 15, 2026 | May 18, 2026 |
TLSI | David PatienceChief Financial Officer | Open market purchase$17.3K | +2.6% | $2.43 | $17.3K | May 15, 2026 | May 18, 2026 |
TLSI | Gary B. GordonDirector | Open market purchase$24.6K | +16.0% | $2.46 | $24.6K | May 15, 2026 | May 18, 2026 |
TLSI | Mary T. SzelaCEO and President | Open market sell$61.4K | -2.1% | $3.85 | $61.4K | Mar 17, 2026 | Mar 20, 2026 |
TLSI | Jodi DevlinChief of Clinical Operations | Open market sell$1.12K | -0.3% | $4.12 | $1.12K | Mar 16, 2026 | Mar 20, 2026 |
TLSI | Bryan F. CoxChief of Research | Open market sell$2.39K | -0.4% | $4.12 | $2.39K | Mar 16, 2026 | Mar 20, 2026 |
TLSI | Richard MarshakChief Commercial Officer | Open market sell$1.73K | -0.4% | $4.12 | $1.73K | Mar 16, 2026 | Mar 20, 2026 |
TLSI | Jennifer StevensChief Regulatory Officer | Open market sell$3.19K | -0.6% | $4.12 | $3.19K | Mar 16, 2026 | Mar 20, 2026 |
TLSI | Jodi DevlinChief of Clinical Operations | Open market sell$7.25K | -1.8% | $4.09 | $7.25K | Mar 12, 2026 | Mar 20, 2026 |
TLSI | Bryan F. CoxChief of Research | Open market sell$6K | -0.9% | $4.09 | $6K | Mar 12, 2026 | Mar 20, 2026 |
TLSI | Richard MarshakChief Commercial Officer | Open market sell$6.5K | -1.4% | $4.09 | $6.5K | Mar 12, 2026 | Mar 20, 2026 |
TLSI | Jennifer StevensChief Regulatory Officer | Open market sell$6.35K | -1.2% | $4.09 | $6.35K | Mar 12, 2026 | Mar 20, 2026 |
TLSI | Jodi DevlinChief of Clinical Operations | Open market sell$4.8K | -1.2% | $4.13 | $4.8K | Mar 11, 2026 | Mar 20, 2026 |
TLSI | Bryan F. CoxChief of Research | Open market sell$4.7K | -0.7% | $4.13 | $4.7K | Mar 11, 2026 | Mar 20, 2026 |
TLSI | Richard MarshakChief Commercial Officer | Open market sell$5.98K | -1.3% | $4.13 | $5.98K | Mar 11, 2026 | Mar 20, 2026 |
TLSI | Jennifer StevensChief Regulatory Officer | Open market sell$4.97K | -0.9% | $4.13 | $4.97K | Mar 11, 2026 | Mar 20, 2026 |
TLSI | Mary T. SzelaCEO and President | Open market sell$18K | -0.6% | $4.13 | $18K | Mar 11, 2026 | Mar 20, 2026 |
TLSI | David PatienceChief Financial Officer | Open market purchase$15K | +1.4% | $4.10 | $15K | Feb 23, 2026 | Feb 23, 2026 |
TLSI | Gary B. GordonDirector | Open market purchase$40K | Not reported | $4.10 | $40K | Feb 23, 2026 | Feb 23, 2026 |
TLSI | William ValleDirector | Open market purchase$125K | Not reported | $4.10 | $125K | Feb 23, 2026 | Feb 23, 2026 |
TLSI | Mary T. SzelaCEO and President | Open market purchase$125K | +4.1% | $4.10 | $125K | Feb 23, 2026 | Feb 23, 2026 |
TLSI | Michael P. StanskyDirector | Open market purchase$481K | +13.5% | $4.10 | $481K | Feb 23, 2026 | Feb 23, 2026 |
TLSI | Michael P. StanskyDirector | Open market purchase$1M | +32.8% | $4.10 | $1M | Feb 23, 2026 | Feb 23, 2026 |